AETERDERM PURILAX Sub-Q with Lidocaine (1 × 1,1 ml)

AETERDERM PURILAX Sub-Q with lidocaine is an advanced dermal filler designed for aesthetic medicine procedures that require effective volume restoration, facial contouring, and the enhancement of facial proportions. Its formula is based on cross-linked hyaluronic acid at a concentration of 24 mg/ml, which provides excellent filling properties and the ability to maintain the desired volume.

The product features a monophasic, homogeneous gel structure characterized by carefully balanced viscoelastic properties, high cohesivity, and elasticity. The manufacturing technology employed ensures a stable consistency, which facilitates even distribution within the tissues, precise contouring, and a natural-looking result in the treated areas.

The Sub-Q variant is designed for subcutaneous administration, specifically for procedures aimed at restoring volume and shaping soft tissues. The gel’s rheological properties help maintain the intended shape and provide structural support to the contoured areas.

The formula is enriched with 0.3% lidocaine, which acts as a local anesthetic to help minimize discomfort during injections, thereby enhancing patient comfort throughout the procedure.

The manufacturer utilizes highly purified hyaluronic acid and a production process that ensures a uniform gel structure. According to the provided data, the product is characterized by low endotoxin levels and a controlled, minimal content of residual cross-linking agents. According to the manufacturer, the results of treatments using PURILAX Sub-Q can last for up to 18 months. The actual duration depends on individual physiological factors, the treatment area, the amount of product administered, and the injection technique used.

Treatment benefits:

• Restoration of lost facial tissue volume.
  
• Contouring and refinement of the facial shape.
  
• Definition of the chin and jawline.
  
• Increased cheek volume and enhancement of the cheekbones.
  
• Smoothing of deep wrinkles and folds.
  
• Improvement of facial proportions and harmony.
  
• Support for soft tissues.
  
• Natural-looking contouring results.
  
• Long-lasting volumizing effect.

Active ingredients:

• Cross-linked hyaluronic acid – 24 mg/ml – an ingredient with water-binding and tissue-volumizing properties, used for facial contouring, restoring lost volume, and correcting wrinkles and folds.
  
• Lidocaine – 3 mg/ml (0.3%) – a local anesthetic agent that reduces pain and discomfort during injections.

Technology and product properties:

AETERDERM PURILAX Sub-Q utilizes a monophasic hyaluronic acid gel technology, developed to achieve optimal stability, cohesivity, and shaping properties.

Key product features:

• Monophasic gel structure – ensures a uniform consistency and facilitates even distribution of the product.
  
• High cohesivity – supports the integrity of the gel and helps maintain the added volume.
  
• Optimized viscoelasticity – provides adequate tissue support and helps preserve the contouring effect.
  
• Elasticity and plasticity – allow the product to adapt to the treated area.
  
• Uniform cross-linking structure – promotes stability and predictable physical properties of the gel.
  
• Controlled extrusion force – facilitates smooth administration of the product during the procedure.

Package contents:

• 1 × pre-filled syringe (1.1 ml).
• 2 × needle – 25G × 1/2″.

Product for use exclusively by professionals.
By choosing to purchase, you declare that you are a physician or a cosmetologist trained in the field of aesthetic medicine.